US AI in Epidemiology Market Insight
Published: 26 May 2026 | Report Format: Electronic (PDF)
The United States AI in Epidemiology market is projected to grow at a CAGR of 21.7% during the forecast period from 2025 to 2035, driven by increasing adoption of AI-powered disease surveillance systems, predictive healthcare analytics, and public health modernization initiatives across the country.
U.S. AI in Epidemiology Market Insights Forecasts to 2035
- The US AI in Epidemiology Market Size Was Estimated at USD 2.24 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 21.7% from 2025 to 2035
- The US AI in Epidemiology Market Size is Expected to Reach USD 15.84 Billion by 2035
Notable Insights for U.S. AI in Epidemiology Market
- By component, AI-powered epidemiology software platforms dominated the U.S. AI in epidemiology market with nearly 59% share in 2025.
- The United States government allocated more than USD 20.3 Billion toward healthcare data modernization, infectious disease preparedness, AI-assisted healthcare analytics, and epidemiological monitoring infrastructure between 2024 and 2026, accelerating nationwide adoption of AI-driven public health technologies.
- Approximately USD 8.1 Billion was invested across the U.S. healthcare ecosystem for cloud-based epidemiological platforms, AI-enabled disease surveillance systems, predictive healthcare analytics, and advanced population health monitoring technologies.
- Infectious disease surveillance emerged as the leading application segment with approximately 35% market share in 2025, supported by increasing federal focus on national health security and real-time epidemiological intelligence capabilities.
Download the eBook (ToC)
Research Methodologies Used to Analyze the United States AI in Epidemiology Market
This report regarding the U.S. AI in epidemiology market is based on a combination of primary and secondary research methodologies. Approximately 70% of the market assessment is derived from secondary research sources, while nearly 30% is supported by primary interviews conducted with epidemiologists, healthcare AI developers, hospital administrators, public health officials, pharmaceutical researchers, healthcare IT specialists, clinical data scientists, and healthcare analytics executives operating across the United States healthcare industry. Secondary research sources include publications and databases from the CDC, NIH, HHS, healthcare technology journals, epidemiological research reports, AI healthcare investment studies, population health analytics publications, government healthcare databases, company annual reports, and public health intelligence reports related to disease surveillance and healthcare AI systems.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the US AI in Epidemiology market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States AI in Epidemiology Market
- IBM Corporation
- Oracle Corporation
- Google LLC
- Microsoft Corporation
- Palantir Technologies Inc.
- IQVIA Holdings Inc.
- SAS Institute Inc.
- Health Catalyst Inc.
- Others
Recent Developments:
- In April 2026, Oracle Corporation invested approximately USD 245 Million toward expanding AI-enabled healthcare analytics infrastructure in the United States, improving epidemiological data processing efficiency by nearly 20% across integrated healthcare systems nationwide.
- In November 2025, Palantir Technologies Inc. enhanced its AI-driven disease surveillance platform for public health agencies, supporting approximately 25% faster outbreak identification and predictive epidemiological response capabilities.
Market Segmentation:
United States AI in Epidemiology Market, By Component
- Software
- Services
- Hardware
United States AI in Epidemiology Market, By Application
- Infectious Disease Surveillance
- Outbreak Prediction & Forecasting
- Population Health Management
- Clinical Data Analytics
- Pandemic Preparedness
- Others
United States AI in Epidemiology Market, By End User
- Government Health Agencies
- Hospitals & Healthcare Providers
- Research Institutions
- Pharmaceutical & Biotechnology Companies
- Public Health Organizations
- Others
Expert Views:
The U.S. AI in epidemiology market is expected to witness strong long-term growth, primarily driven by increasing deployment of AI-powered healthcare intelligence systems, rising emphasis on predictive public health management, and expanding federal investments in healthcare modernization initiatives. Industry experts believe infectious disease surveillance and outbreak prediction applications will continue leading market demand, while advancements in machine learning algorithms, cloud-based epidemiological platforms, and AI-assisted healthcare analytics are expected to accelerate innovation across the healthcare ecosystem.
Author: Govind and Krishna By Spherical Insights and Consulting